New combo therapy aims to wipe out early anal cancer
Disease control
Recruiting now
This study is testing a new treatment approach for early-stage anal cancer. It combines an immunotherapy drug (pembrolizumab) with two chemotherapy drugs and radiation. The main goal is to see if this combination can completely eliminate detectable cancer and keep it from coming …
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC